Share

    


Home / Search Results

Search Results

Search Again?

Filter By Topic

In a letter to congressional leadership, ACCC joined 16 other healthcare associations and coalitions urging Congress to extend Medicare's 5 percent advanced alternative payment model (APM) incentive payments in an end-of-year legislative package. Originally authorized under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), these incentive payments were intended to support providers …
Exercise and Diet in Cancer Patients: Current Guidelines Carolyn M. Matthews, MD October 2022 Disclosure of Conflicts of Interest Carolyn M. Matthews, MD, has no relevant financial relationships to disclose. Role of Nutrition in Oncology Community interest Oncologist Research Prevention/treatment/survivorship Overweight/obesity Cancer causation …
ACCCBuzz spoke with Dr. Dan Vogl to learn more about the treatment options available to patients with multiple myeloma, including the benefits of adding anti-CD38 monoclonal antibodies in either first- or second-line treatment.
ACCC—the how-to organiza- tion for the multidisciplinary cancer care team— has a long and rich history of bringing forward technology- driven solutions. More than a decade ago in 2011, ACCC created its Innovator Award program to recognize visionary ideas and compelling solutions in oncology. MultiCare Health System, MultiCare Regional Cancer Center was recognized for leveraging technology …
September 28, 2022
Motif Seattle 1415 5th Ave. Seattle, WA 98101 206.971.8000 Join the Montana State Oncology Society for a comprehensive update on solid tumors and hematologic disorders at the Fred Hutchinson Cancer Center 13th Annual Comprehensive Hematology & Oncology Review Course. This accredited, multi-day, in-person program will cover data supporting guidelines, recommendations, and recent advances regarding …
Technological solutions can be used to identify and mitigate the effects of health disparities, helping clinicians understand the factors that affect care delivery.
Microsoft Word - Harrisburg- PA ORM Agenda.docx Harrisburg, PA, Fall ORM Agenda 9:00 – 9:45 AM EST Breakfast 9:45 – 10:30 AM EST Welcome and ACCC Policy Update Matt Devino, MPH, Director of Cancer Care Delivery & Health Policy Association of Community Cancer Centers With the release of the proposed Hospital Outpatient Prospective Payment System and Medicare Physician Fee …
Understanding Immune Suppression in Pancreas Cancer: A Key Role for Gamma Delta T Cells Johnathan Ebben, MD, PhD Oncology Fellow, University of Wisconsin- Madison Carbone Cancer Center WAHO 2022 Annual Conference Disclosure of Conflicts of Interest Johnathan Ebben, MD, PhD, has the following financial relationship to disclose: • Cofounder, Nano RED The Challenge …
Gastrointestinal Oncology Nataliya Uboha, MD, PhD, Associate Professor University of Wisconsin, Carbone Cancer Center Disclosure of Conflicts of Interest Nataliya Uboha, MD, PhD, has the following financial relationships to disclose: • Consulting: QED, Taiho Inc., Incyte, AstraZeneca, Pfizer, Boston Gene, Helsinn. • Research Funding: Taiho Inc, Ipsen, EMD Serono. • Long position …
Medical College of Wisconsin CONFIDENTIAL. Do not share. Precision Oncology(PO): “The new kid on the block” POGI Aditya Shreenivas MD MS Assistant Professor Division of Hematology & Oncology GU Lung HN/BC O Medical College of Wisconsin CONFIDENTIAL. Do not share. Aditya Shreenivas, MD, MS, has the following financial relationships to disclose: • Research …
HLH-like toxicity due to CAR T-cell therapy WAHO 2022 conference Fateeha Furqan, MD PYG-6 Hematology/Oncology Medical College of Wisconsin September 24, 2022 2 Disclosure of Conflicts of Interest • Fateeha Furqan, MD, has no relevant financial relationships to disclose. 3 Case • 60 years old man with relapsed/refractory mantle cell lymphoma was admitted to …
LUNG CANCER Smitha Menon, MD Associate Professor of Medicine Medical College of W isconsin Milwaukee Disclosure of Conflicts of Interest Smitha Menon, MD, has the following financial relationships to disclose: • Research Support (Institution): Eli Lilly, Merck, Mirati, Harpoon UPDATE IN NON-SMALL …
Hamid Emamekhoo, MD Assistant Professor Department of Medicine Kidney and Bladder Cancer Updates 9/24/2022 COI Hamid Emamekhoo, MD, has the following financial relationships to disclose: • Exelixis: Consultant (advisory board) • Seattle Genetics: Consultant (advisory board) Objectives • Kidney Cancer: o List different treatment regimens approved for …
Gundersen Lutheran Medical Center, Inc. | Gundersen Clinic, Ltd. Rural Cancer Care Emily Westergard, DO Hematology/Oncology Fellow Gundersen Health System, La Crosse, WI Gundersen Lutheran Medical Center, Inc. | Gundersen Clinic, Ltd. Disclosure of Conflicts of Interest • Emily Westergard, DO, has no relevant financial relationships to disclose. Gundersen Lutheran …
ONCOLOGY HEALTH DISPARITIES IN WISCONSIN Kirsten Beyer, PhD, MPH, MS; Associate Professor, Medical College of Wisconsin Wisconsin Association of Hematology and Oncology Annual Conference Hilton Milwaukee City Center; Milwaukee, WI September 24, 2022 DISCLOSURE OF CONFLICTS OF INTEREST • Kristen Beyer, PhD, MPH, MS, has no relevant financial relationships to disclose. OVERVIEW …
Care optimization is everything in today’s rapidly changing healthcare landscape. Learn how ACCC's nationwide quality improvement (QI) initiative helped Southern Ohio Medical Center Cancer Center develop and implement plans to support the optimization of care for patients diagnosed with Stages III and IV non-small cell lung cancer (NSCLC).
ACCC Staff, Board of Trustees, and Executive Committee members mourn the loss of the Association’s former Chief Financial Officer (CFO), Lois Utterback. Living with leukemia for more than five years, Lois passed away on September 19, surrounded by family and friends. She is survived by her husband Greg, and two sisters. Lois served as ACCC’s Chief Financial Officer for more than 30 years. Her connections …
On September 16, the National Comprehensive Cancer Network convened experts and stakeholders in D.C. for a policy summit spotlighting today’s cancer screening and prevention landscape. Learn what speakers discussed, including what changes need to happen to create an equitable future for all people at risk—or not—for cancer.
Rockville, MD – A staggering 85% of cancer patients may suffer from malnutrition during treatment. Additionally, malnutrition accounts for approximately 10% to 20% of mortality in cancer patients. Lack of timely diagnosis and appropriate management of malnutrition can negatively impact patient outcomes. Negative outcomes include reduced treatment tolerance and efficacy, increased risk for …
Hear how malnutrition affects people with cancer in different ways, even impacting cancer treatment plans.